Back to search

Article

RANKL Immunisation Inhibits Prostate Cancer Metastasis by Modulating EMT Through a RANKL-dependent Pathway

2020-10-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Prostate cancer (PCa) morbidity in the majority of patients is due to metastatic events, which are a clinical obstacle. Therefore, a better understanding of the mechanism underlying metastasis is imperative if we are to develop novel therapeutic strategies. Receptor activator of nuclear factor kappa-B (NF-κB) ligand (RANKL) regulates bone remodelling. RANKL was...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc09c050-261f-5c71-a63e-2b8b32265d23
DOI
10.21203/rs.3.rs-98591/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RANKL&nbsp;Immunisation Inhibits Prostate Cancer Metastasis by Modulating EMT&nbsp;Through a RANKL-dependent PathwayDOI 10.21203/rs.3.rs-98591/v1
Select a neighboring publication to make it the new centre.